Review of the epidemiology of hepatitis C in the East Midlands in 2017. The report provides updates on trends, areas of high burden of disease and at risk population groups and identify opportunities for interventions to reduce disease burden.
NHS England will routinely commission antivirals for adults with acute hepatitis C (HCV), including the treatment of acute HCV infection in immunosuppressed adults (e.g. post transplantation patients) in accordance with the criteria set out in this document.
This report focuses on the epidemiology of hepatitis C in Yorkshire and Humber using mainly routinely available surveillance data.
This working document, written by Public Health England’s (PHE) Hepatitis C Virus Resistance Group, aims to support clinicians treating people with HCV, where the issue of resistance may be a factor in clinical decision-making.
This report summarises the content and completeness of data contained within the Hepatitis C patient registry and treatment outcome system at the end of April 2018, enabling a preliminary assessment of HCV treatment and its monitoring in England.
Hepatitis B and C virus infections represent a major public health problem. In England, and elsewhere in the UK, injecting drug use is the major risk factor for acquiring hepatitis C infection. Injecting drug use is also a risk factor for hepatitis
Despite the publication of the Hepatitis C Action Plan for England in 2004, there is evidence of considerable variation in hepatitis C testing, treatment, care and support services available in England. In addition, little is known about the provision and
The evidence identified for this review suggests that people from high risk groups may hold concepts of illness and disease that differ from biomedical understandings. Consequently people from high risk groups may have an incomplete or confused understanding of the
This report collates routinely available data on the burden of liver disease and describes its relationship with inequalities. We hope that it will be a useful resource for Directors of Public Health, health and wellbeing boards, commissioners and providers of
The Preventing Alcohol Harm in Liverpool and Knowsley (PrevAIL) project aims to estimate the prevalence of early stage liver disease and identifying optimal ways of engaging people with screening. To do this, the study uses conventional biomarkers of alcohol use
Annual report for acute hepatitis B in England, details confirmed hepatitis B infections reported to PHE by laboratories in England.
Information for GPs and practice nurses It recommends: When pregnant women attend for vaccination during pregnancy Ask mum if they have screened positive for hepatitis B Tell her to register their baby at the surgery as soon as possible when
Laboratory reports of hepatitis A and C reported to Public Health England, laboratory-confirmed hepatitis A virus and hepatitis C reports in England and Wales in 2018.
The most recent national estimates suggest that around 200,000 individuals are chronically infected with hepatitis C virus (HCV) in the UK.
Hepatitis C in the North West is still a major public health concern, however, rates since 2014 have remained stable. Estimates suggest at least 40,000 people across the North West acquired hepatitis C infection, and of those 27,000 have developed